A recent study showed induction of immunity against metastatic melanoma through vaccination with mature DCs loaded with melanoma antigens (MART-1, MAGE-3, gp100 and tyrosinase) processed through melanoma constitutive proteasomes for presentation by MHC class I to cognate T cells. This evidence concerns the gene PMEL and metastatic melanoma.